Obermatt
See Similar Stocks →

OrganiGram Holdings

TOR:OGI · CA68617J1003
PharmaceuticalsSmall

360

39
Profit price81
Owner Earnings Yield1
Dividend Yield1
Price/Sales93
EV / Gross Profit63
Price/Book68
Return on Capital52
Cash Return on Capital46
Return on Equity49
EBIT Margin40
Gross Profitability47
Accruals44
Owner Earnings Margin42
Sales growth78
Profit Growth5
Owner Earnings Growth9
Reinvestment5
Price momentum26
Debt load26
Refinancing98
Debt Payback1
Liquidity100
Analyst ratings36
Opinion Changes91
Price Target Upside59
Market mood81
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

OrganiGram Holdings doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryCanada
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeTSX
Employees536
Websiteorganigram.ca
ISINCA68617J1003
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
CannabisAlternative MedicineNutraceuticalCommunity and LifestyleFood and BeverageHealth Care

Description

Organigram Global Inc. (Organigram) is a Canadian licensed producer of cannabis and cannabis-derived products for consumers in Canada. The company also has various international business relationships that it continuously seeks to develop in order t…

Analysis

Middle-of-the-road

Organigram Global Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is adequate. The company scores 4/20 on our value-creation score: not creating value. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
69
2023202420252026

All-time high

93

Jan 2025

All-time low

69

Mar 2026

Average rank

77

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
93
81
84
32
Price/Earnings
55
13
13
30
Price/Book
68
67
75
75
Dividend Yield
1
1
1
1
Value (overall)
79
70
78
49

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare OrganiGram Holdings with its peers
Cronos Group
TOR:CRON
45
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
SNDL
NAQ:SNDL
45
CountryCanada
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Trulieve Cannabis
CNX:TRUL
39
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Curaleaf Holdings
TOR:CURA
14
CountryUSA
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →
Cresco Labs
CNX:CL
43
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
SIGA Technologies
NMQ:SIGA
63
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →